• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性脑淋巴瘤和胶质母细胞瘤:DCE T1 和 DSC T2 MRI 灌注成像的评估。

Primary brain lymphoma and glioblastoma: evaluation of DCE T1 and DSC T2 MRI perfusion findings.

机构信息

Department of Radiology, Ankara Sincan Educational and Research Hospital, Ankara, Turkey.

Department of Radiology, Bilkent City Hospital, Ankara, Turkey.

出版信息

Acta Radiol. 2024 Jul;65(7):800-807. doi: 10.1177/02841851241256781. Epub 2024 May 26.

DOI:10.1177/02841851241256781
PMID:38798137
Abstract

BACKGROUND

The accurate differentiation of primary central nervous system lymphoma (PCNSL) from glioblastoma multiforme (GBM) is clinically crucial due to the different treatment strategies between them.

PURPOSE

To define magnetic resonance imaging (MRI) perfusion findings in PCNSL to make a safe distinction from GBM with dynamic contrast-enhanced (DCE) T1 and DSC T2 MRI perfusion findings.

MATERIAL AND METHODS

This retrospective analysis included 19 patients with histopathologically diagnosed PCNSL and 21 individuals with GBM. DCE T1 vascular permeability perfusion values including K-trans, Ve, Kep, IAUGC, and DSC T2 perfusion values including cerebral blood volume (CBV) and cerebral blood flow (CBF) in axial sections from the pathological lesion and contralateral normal brain parenchyma were measured quantitatively using region of interest analysis.

RESULTS

The study observed no statistically significant difference between patients with PCNSL (T/B cell) and GBM in the median values of DCE T1 perfusion ratios ( > 0.05). Nevertheless, the DSC T2 perfusion ratios showed a substantial distinction between the two groups. In contrast to patients with PCNSL (1.185 vs. 1.224, respectively), those with GBM had higher median levels of r-CBV and r-CBF (2.898 vs. 2.467, respectively; 0.01). A cutoff value of ≤1.473 for r-CBV (Lesion/N) and ≤1.6005 for r-CBF (Lesion/N) was found to estimate the positivity of PCNSL.

CONCLUSION

DSC T2 MRI perfusion values showed lower r-CBV and r-CBF values in PCNSL patients compared to GBM patients. According to the findings, r-CBV and r-CBF are the most accurate MRI perfusion parameters for distinguishing between PCSNL and GBM.

摘要

背景

原发性中枢神经系统淋巴瘤(PCNSL)与多形性胶质母细胞瘤(GBM)的准确区分在临床上至关重要,因为它们的治疗策略不同。

目的

通过动态对比增强(DCE)T1 和 DSC T2 MRI 灌注成像来定义 PCNSL 的磁共振成像(MRI)灌注表现,以安全地区分 PCNSL 与 GBM。

材料和方法

本回顾性分析纳入了 19 例经组织病理学诊断为 PCNSL 的患者和 21 例 GBM 患者。使用感兴趣区分析对轴向切片中的 DCE T1 血管通透性灌注值(包括 K-trans、Ve、Kep、IAUGC)和 DSC T2 灌注值(包括脑血容量 [CBV] 和脑血流 [CBF])进行定量测量。

结果

研究发现,PCNSL(T/B 细胞)患者与 GBM 患者的 DCE T1 灌注比值中位数无统计学差异(>0.05)。然而,两组间 DSC T2 灌注比值存在显著差异。与 PCNSL 患者(分别为 1.185 和 1.224)相比,GBM 患者的 r-CBV 和 r-CBF 中位数水平更高(分别为 2.898 和 2.467; 0.01)。发现 r-CBV(病灶/正常)≤1.473 和 r-CBF(病灶/正常)≤1.6005 为 PCNSL 阳性的截断值。

结论

与 GBM 患者相比,PCNSL 患者的 DSC T2 MRI 灌注值的 r-CBV 和 r-CBF 值较低。根据这些发现,r-CBV 和 r-CBF 是区分 PCSNL 和 GBM 的最准确的 MRI 灌注参数。

相似文献

1
Primary brain lymphoma and glioblastoma: evaluation of DCE T1 and DSC T2 MRI perfusion findings.原发性脑淋巴瘤和胶质母细胞瘤:DCE T1 和 DSC T2 MRI 灌注成像的评估。
Acta Radiol. 2024 Jul;65(7):800-807. doi: 10.1177/02841851241256781. Epub 2024 May 26.
2
Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.使用动态磁敏感对比磁共振成像进行渗透性测量可增强原发性中枢神经系统淋巴瘤与胶质母细胞瘤的鉴别诊断。
Eur Radiol. 2019 Oct;29(10):5539-5548. doi: 10.1007/s00330-019-06097-9. Epub 2019 Mar 15.
3
Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI.脑胶质母细胞瘤与原发性中枢神经系统淋巴瘤的鉴别诊断:基于 DSC-MRI 获得的动脉输入函数的 DCE-MRI 参数的应用。
Eur Radiol. 2021 Dec;31(12):9098-9109. doi: 10.1007/s00330-021-08044-z. Epub 2021 May 18.
4
Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.基于多参数成像的淋巴瘤与胶质母细胞瘤鉴别:利用T1灌注、扩散及磁敏感加权磁共振成像
Clin Radiol. 2018 Nov;73(11):986.e7-986.e15. doi: 10.1016/j.crad.2018.07.107. Epub 2018 Sep 7.
5
Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma.扩散加权成像及动态对比增强磁共振成像对原发性中枢神经系统淋巴瘤与胶质母细胞瘤鉴别诊断的定量评估
J Comput Assist Tomogr. 2017 Nov/Dec;41(6):898-903. doi: 10.1097/RCT.0000000000000622.
6
Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient.原发中枢神经系统淋巴瘤和非典型性脑胶质瘤:基于动态对比增强磁共振的初始曲线下面积和表观扩散系数的鉴别诊断。
Eur Radiol. 2017 Apr;27(4):1344-1351. doi: 10.1007/s00330-016-4484-2. Epub 2016 Jul 19.
7
Multiparametric analysis from dynamic susceptibility contrast-enhanced perfusion MRI to evaluate malignant brain tumors.动态对比增强磁共振灌注成像多参数分析评估脑恶性肿瘤。
J Neuroimaging. 2024 Mar-Apr;34(2):257-266. doi: 10.1111/jon.13183. Epub 2024 Jan 3.
8
Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy.使用放化疗期间的时相灌注变化预测胶质母细胞瘤患者的生存和进展。
Magn Reson Imaging. 2020 May;68:106-112. doi: 10.1016/j.mri.2020.01.012. Epub 2020 Jan 28.
9
Clinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from Glioblastoma.动态磁敏感对比 MRI 评估血管通透性的临床价值:在鉴别高血运性原发性中枢神经系统淋巴瘤与胶质母细胞瘤方面提高诊断性能。
AJNR Am J Neuroradiol. 2018 Aug;39(8):1415-1422. doi: 10.3174/ajnr.A5732. Epub 2018 Jul 19.
10
Improved performance of non-preloaded and high flip-angle dynamic susceptibility contrast perfusion-weighted imaging sequences in the presurgical differentiation of brain lymphoma and glioblastoma.非预加载和高翻转角动态磁敏感对比灌注加权成像序列在脑淋巴瘤和胶质母细胞瘤术前鉴别诊断中的性能改善。
Eur Radiol. 2023 Dec;33(12):8800-8808. doi: 10.1007/s00330-023-09917-1. Epub 2023 Jul 13.